Prevalence of overweight and obesity in bipolar patients

Journal of Clinical Psychiatry

Volumn 61, Issue 3, 2000, Pages 179-184

  Elmslie, Jane L ^a   Silverstone, J Trevor ^a   Mann, Jim I ^a   Williams, Shelia M ^a   Romans, Sarah E ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LITHIUM; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BODY FAT; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; OBESITY; PREVALENCE; PRIORITY JOURNAL; THYROID FUNCTION; WEIGHT GAIN;

EID: 0033994322     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0306     Document Type: Article

References (25)

1. Pi-Sunyer FX. Health implications of obesity. Am J Clin Nutr 1991;53: 1595S-1603S
2. Vestergaard P, Poulstrup M, Schou M. Prospective studies in a lithium cohort, 3: tremor, weight gain, diarrhea, psychological complaints. Acta Psychiatr Scand 1988;78:434-441
3. Gitlin MJ, Cochran SD, Jamison KR. Maintenance lithium treatment: side effects and compliance. J Clin Psychiatry 1989;50:127-131
4. Jamison KR, Akiskal HS. Medication compliance in patients with bipolar disorder. Psychiatr Clin North Am 1983;6:175-192
5. Gopalaswamy AK, Morgan R. Too many chronically mentally disabled patients are too fat. Acta Psychiatr Scand 1985;72:254-258
6. Silverstone T, Smith G, Goodall E. Prevalence of obesity in patients receiving depot antipsychotics. Br J Psychiatry 1988;153:214-217
7. Stedman T, Welham J. The distribution of adipose tissue in female patients receiving psychotropic drugs. Br J Psychiatry 1993;162:249-250
8. Allison DB, Fontaine KR, Heo M, et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999;60:215-220
9. Muller-Oerlinghausen B, Passoth PM, Poser W, et al. Impaired glucose tolerance in long-term lithium-treated patients. Int Pharmacopsychiatry 1979;14:350-362
10. Chen Y, Silverstone T. Lithium and weight gain. Int Clin Psychopharmacol 1990;5:217-225
11. Isojarvi JI, Laatikainen TJ, Knip M, et al. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996;39:579-584
12. Cassidy W, Flanagan N, Spellman M, et al. Clinical observations in manic-depressive disease: a quantitative study of one hundred manic-depressive patients and fifty medically sick controls. JAMA 1957;164:1535-1546
13. Salata R, Klein I. Effects of lithium on the endocrine system: a review. J Lab Clin Med 1987;110:130-136
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
15. Mann J, Nye T, Wilson B, et al. Life in New Zealand Commission Report: Health. Wellington, New Zealand: Hillary Commission for Recreation and Sport; 1991
16. James P. Obesity: a preventable disease. Report From the International Obesity Task Force (IOTF). Geneva, Switzerland: World Health Organization; 1996
17. Kannel WB, Cupples LA, Ramaswami R, et al. Regional obesity and risk of cardiovascular disease: the Framingham Study. J Clin Epidemiol 1991; 44:183-190
18. Klesges RC, Klesges LM, Meyers AW. Relationship of smoking status, energy balance, and body weight: analysis of the Second National Health and Nutrition Examination Survey. J Consult Clinical Psychol 1991;59: 899-905
19. Stunkard AJ. Socioeconomic status and obesity. Ciba Foundation Symposium 1996;201:174-182; discussion 182-193
20. Sattar N, Tan CE, Han TS, et al. Associations of indices of adiposity with atherogenic lipoprotein subfractions. Int J Obesity Relat Metab Disord 1998;22:432-439
21. Muller-Oerlinghausen B, Passoth PM, Poser W, et al. Effect of long-term treatment with neuroleptics or lithium salts on carbohydrate metabolism. Arzneimittelforschung 1978;28:1522-1524
22. Paykel ES, Mueller PS, De La Vergne PM. Amitriptyline weight gain and carbohydrate craving. Br J Psychiatry 1973;123:501-507
23. Bentsen K, Gram L, Veje A. Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate. Acta Neurol Scand 1983;67:235-241
24. Invitti C, Danesi L, Dubini A, et al. Neuroendocrine effects of chronic administration of sodium valproate in epileptic patients. Acta Endocrinol (Copenh) 1988;118:381-388
25. Bocchetta A, Bernardi F, Burrai C, et al. The course of thyroid abnormalities during lithium treatment: a two-year follow-up study. Acta Psychiatr Scand 1992;86:38-41